Aged-senescent cells contribute to impaired heart regeneration

Fiona C. Lewis-McDougall, Prashant J. Ruchaya, Eva Domenjo-Vila, Tze Shin Teoh, Larissa Prata, Beverley J. Cottle, James E. Clark, Prakash P. Punjabi, Wael Awad, Daniele Torella, Tamara Tchkonia, James L Kirkland, Georgina M. Ellison-Hughes

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Aging leads to increased cellular senescence and is associated with decreased potency of tissue-specific stem/progenitor cells. Here, we have done an extensive analysis of cardiac progenitor cells (CPCs) isolated from human subjects with cardiovascular disease, aged 32–86 years. In aged subjects (>70 years old), over half of CPCs are senescent (p16 INK4A , SA-β-gal, DNA damage γH2AX, telomere length, senescence-associated secretory phenotype [SASP]), unable to replicate, differentiate, regenerate or restore cardiac function following transplantation into the infarcted heart. SASP factors secreted by senescent CPCs renders otherwise healthy CPCs to senescence. Elimination of senescent CPCs using senolytics abrogates the SASP and its debilitative effect in vitro. Global elimination of senescent cells in aged mice (INK-ATTAC or wild-type mice treated with D + Q senolytics) in vivo activates resident CPCs and increased the number of small Ki67-, EdU-positive cardiomyocytes. Therapeutic approaches that eliminate senescent cells may alleviate cardiac deterioration with aging and restore the regenerative capacity of the heart.

Original languageEnglish (US)
Article numbere12931
JournalAging Cell
Volume18
Issue number3
DOIs
StatePublished - Jun 1 2019
Externally publishedYes

Fingerprint

Regeneration
Stem Cells
Cell Aging
Phenotype
Cyclin-Dependent Kinase Inhibitor p16
Telomere
Cardiac Myocytes
DNA Damage
Cardiovascular Diseases
Cell Count
Transplantation

Keywords

  • aging
  • cardiac regeneration
  • cardiac repair
  • myocardial infarction
  • p16INK4a
  • progenitor cells
  • senescence
  • senescence-associated secretory phenotype
  • senolytics

ASJC Scopus subject areas

  • Aging
  • Cell Biology

Cite this

Lewis-McDougall, F. C., Ruchaya, P. J., Domenjo-Vila, E., Shin Teoh, T., Prata, L., Cottle, B. J., ... Ellison-Hughes, G. M. (2019). Aged-senescent cells contribute to impaired heart regeneration. Aging Cell, 18(3), [e12931]. https://doi.org/10.1111/acel.12931

Aged-senescent cells contribute to impaired heart regeneration. / Lewis-McDougall, Fiona C.; Ruchaya, Prashant J.; Domenjo-Vila, Eva; Shin Teoh, Tze; Prata, Larissa; Cottle, Beverley J.; Clark, James E.; Punjabi, Prakash P.; Awad, Wael; Torella, Daniele; Tchkonia, Tamara; Kirkland, James L; Ellison-Hughes, Georgina M.

In: Aging Cell, Vol. 18, No. 3, e12931, 01.06.2019.

Research output: Contribution to journalArticle

Lewis-McDougall, FC, Ruchaya, PJ, Domenjo-Vila, E, Shin Teoh, T, Prata, L, Cottle, BJ, Clark, JE, Punjabi, PP, Awad, W, Torella, D, Tchkonia, T, Kirkland, JL & Ellison-Hughes, GM 2019, 'Aged-senescent cells contribute to impaired heart regeneration', Aging Cell, vol. 18, no. 3, e12931. https://doi.org/10.1111/acel.12931
Lewis-McDougall FC, Ruchaya PJ, Domenjo-Vila E, Shin Teoh T, Prata L, Cottle BJ et al. Aged-senescent cells contribute to impaired heart regeneration. Aging Cell. 2019 Jun 1;18(3). e12931. https://doi.org/10.1111/acel.12931
Lewis-McDougall, Fiona C. ; Ruchaya, Prashant J. ; Domenjo-Vila, Eva ; Shin Teoh, Tze ; Prata, Larissa ; Cottle, Beverley J. ; Clark, James E. ; Punjabi, Prakash P. ; Awad, Wael ; Torella, Daniele ; Tchkonia, Tamara ; Kirkland, James L ; Ellison-Hughes, Georgina M. / Aged-senescent cells contribute to impaired heart regeneration. In: Aging Cell. 2019 ; Vol. 18, No. 3.
@article{81286f79cc9347d2af3ffefafee43a51,
title = "Aged-senescent cells contribute to impaired heart regeneration",
abstract = "Aging leads to increased cellular senescence and is associated with decreased potency of tissue-specific stem/progenitor cells. Here, we have done an extensive analysis of cardiac progenitor cells (CPCs) isolated from human subjects with cardiovascular disease, aged 32–86 years. In aged subjects (>70 years old), over half of CPCs are senescent (p16 INK4A , SA-β-gal, DNA damage γH2AX, telomere length, senescence-associated secretory phenotype [SASP]), unable to replicate, differentiate, regenerate or restore cardiac function following transplantation into the infarcted heart. SASP factors secreted by senescent CPCs renders otherwise healthy CPCs to senescence. Elimination of senescent CPCs using senolytics abrogates the SASP and its debilitative effect in vitro. Global elimination of senescent cells in aged mice (INK-ATTAC or wild-type mice treated with D + Q senolytics) in vivo activates resident CPCs and increased the number of small Ki67-, EdU-positive cardiomyocytes. Therapeutic approaches that eliminate senescent cells may alleviate cardiac deterioration with aging and restore the regenerative capacity of the heart.",
keywords = "aging, cardiac regeneration, cardiac repair, myocardial infarction, p16INK4a, progenitor cells, senescence, senescence-associated secretory phenotype, senolytics",
author = "Lewis-McDougall, {Fiona C.} and Ruchaya, {Prashant J.} and Eva Domenjo-Vila and {Shin Teoh}, Tze and Larissa Prata and Cottle, {Beverley J.} and Clark, {James E.} and Punjabi, {Prakash P.} and Wael Awad and Daniele Torella and Tamara Tchkonia and Kirkland, {James L} and Ellison-Hughes, {Georgina M.}",
year = "2019",
month = "6",
day = "1",
doi = "10.1111/acel.12931",
language = "English (US)",
volume = "18",
journal = "Aging Cell",
issn = "1474-9718",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Aged-senescent cells contribute to impaired heart regeneration

AU - Lewis-McDougall, Fiona C.

AU - Ruchaya, Prashant J.

AU - Domenjo-Vila, Eva

AU - Shin Teoh, Tze

AU - Prata, Larissa

AU - Cottle, Beverley J.

AU - Clark, James E.

AU - Punjabi, Prakash P.

AU - Awad, Wael

AU - Torella, Daniele

AU - Tchkonia, Tamara

AU - Kirkland, James L

AU - Ellison-Hughes, Georgina M.

PY - 2019/6/1

Y1 - 2019/6/1

N2 - Aging leads to increased cellular senescence and is associated with decreased potency of tissue-specific stem/progenitor cells. Here, we have done an extensive analysis of cardiac progenitor cells (CPCs) isolated from human subjects with cardiovascular disease, aged 32–86 years. In aged subjects (>70 years old), over half of CPCs are senescent (p16 INK4A , SA-β-gal, DNA damage γH2AX, telomere length, senescence-associated secretory phenotype [SASP]), unable to replicate, differentiate, regenerate or restore cardiac function following transplantation into the infarcted heart. SASP factors secreted by senescent CPCs renders otherwise healthy CPCs to senescence. Elimination of senescent CPCs using senolytics abrogates the SASP and its debilitative effect in vitro. Global elimination of senescent cells in aged mice (INK-ATTAC or wild-type mice treated with D + Q senolytics) in vivo activates resident CPCs and increased the number of small Ki67-, EdU-positive cardiomyocytes. Therapeutic approaches that eliminate senescent cells may alleviate cardiac deterioration with aging and restore the regenerative capacity of the heart.

AB - Aging leads to increased cellular senescence and is associated with decreased potency of tissue-specific stem/progenitor cells. Here, we have done an extensive analysis of cardiac progenitor cells (CPCs) isolated from human subjects with cardiovascular disease, aged 32–86 years. In aged subjects (>70 years old), over half of CPCs are senescent (p16 INK4A , SA-β-gal, DNA damage γH2AX, telomere length, senescence-associated secretory phenotype [SASP]), unable to replicate, differentiate, regenerate or restore cardiac function following transplantation into the infarcted heart. SASP factors secreted by senescent CPCs renders otherwise healthy CPCs to senescence. Elimination of senescent CPCs using senolytics abrogates the SASP and its debilitative effect in vitro. Global elimination of senescent cells in aged mice (INK-ATTAC or wild-type mice treated with D + Q senolytics) in vivo activates resident CPCs and increased the number of small Ki67-, EdU-positive cardiomyocytes. Therapeutic approaches that eliminate senescent cells may alleviate cardiac deterioration with aging and restore the regenerative capacity of the heart.

KW - aging

KW - cardiac regeneration

KW - cardiac repair

KW - myocardial infarction

KW - p16INK4a

KW - progenitor cells

KW - senescence

KW - senescence-associated secretory phenotype

KW - senolytics

UR - http://www.scopus.com/inward/record.url?scp=85065871555&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065871555&partnerID=8YFLogxK

U2 - 10.1111/acel.12931

DO - 10.1111/acel.12931

M3 - Article

VL - 18

JO - Aging Cell

JF - Aging Cell

SN - 1474-9718

IS - 3

M1 - e12931

ER -